Skip to content
KFF Health News KFF Health News KFF Health News KFF Health News
Donate
  • Donate
  • Connect With Us:
  • Contact
  • X
  • Facebook
  • LinkedIn
  • Instagram
  • RSS
  • Trump 2.0
    • Agency Watch
    • Medicaid Watch
    • State Watch
    • Rural Health Payout
  • Public Health
  • Race & Health
  • Audio
    • KFF Health News Minute
    • What the Health?
    • Health Care Helpline
    • An Arm and a Leg
    • Silence in Sikeston
    • Epidemic
  • Investigations
    • Bill Of The Month
    • Deadly Denials
    • The Body Shops
    • Broken Rehab
    • Guns, Race, and Profit
    • Dead Zone
    • Payback: Tracking Opioid Cash
    • Overpayment Outrage
    • Diagnosis: Debt
    • ALL INVESTIGATIONS
  • More Topics
    • Abortion
    • Aging
    • Climate
    • COVID-19
    • Health Care Costs
    • Insurance
    • Medicaid
    • Medicare
    • Mental Health
    • Pharma
    • Rural Health
    • Uninsured

Search Results

Filter Results

Date
Custom Date Range
Topic
Content Type

Showing 7241-7260 of 131,287 results

Medicare Pricing Talks On 10 Drugs Kick Off With CMS Opening Offers

February 1, 2024 Morning Briefing

The Biden administration sent starting offers in Medicare price negotiations with drugmakers for 10 prescription medications that were previously selected. The companies have until March 2 to respond to initial proposals, with other rounds of talks expected through the spring.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Biogen Abandons Alzheimer’s Drug That Won Controversial Approval

February 1, 2024 Morning Briefing

Neurimmune, the Swiss company that invented Aduhelm, will regain full rights to it from Biogen. The FDA’s accelerated approval of the drug in 2021 was contentious and there has been limited marketplace for and coverage of Aduhelm since.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

First Edition: Feb. 1, 2024

February 1, 2024 Morning Briefing

Today’s early morning highlights from the major news organizations.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
a white box of syringes containing a clear medication with a white and blue label wrapped around each

Surge in Syphilis Cases Leads Some Providers to Ration Penicillin

By Catherine Sweeney, WPLN February 1, 2024 KFF Health News Original

Injectable penicillin is the go-to treatment for syphilis and the only treatment considered safe for pregnant people with the disease. But as rates of syphilis increase across the U.S., a shortage of the injectable has prompted some public health agencies to ration it.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
A photograph of a woman using a smartphone as she sits next to an open suitcase on a bed. Her face is cropped out of view.

More ‘Navigators’ Are Helping Women Travel to Have Abortions

By Lillian Mongeau Hughes February 1, 2024 KFF Health News Original

After the U.S. Supreme Court ended the federal right to an abortion and many states banned the procedure, reproductive health care organizations hired dozens of people to help patients arrange travel and pay for care.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Should Obesity Drugs Be Prioritized? Genetics Test Could Help Decide

January 31, 2024 Morning Briefing

Read recent pharmaceutical developments in KFF Health News’ Prescription Drug Watch roundup.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Perspectives: Supreme Court Must Trust FDA On Mifepristone; What’s Behind The Fentanyl Crisis?

January 31, 2024 Morning Briefing

Read recent commentaries about pharmaceutical issues.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Viewpoints: Misinformation Can Be Deadly; Will We Ever Recover From The Covid Pandemic?

January 31, 2024 Morning Briefing

Editorial writers tackle misinformation, covid, gene therapy, and more.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Utah Gov. Signs Bill Restricting Trans People’s Access To Public Restrooms

January 31, 2024 Morning Briefing

The new anti-trans law also defines the legal definition of “male” and female” based on a person’s genitalia instead of gender identity. Meanwhile, in Florida, trans people can no longer update their driver’s licenses to match gender identity — a move not prompted by any new law.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Gallup Poll Finds Nurses Are Most Trusted Among 23 Major Professions

January 31, 2024 Morning Briefing

Americans trust nurses even more than doctors, the new 2023 Honesty and Ethics poll found: 78% of Americans taking part in the poll felt nurses kept to “very high” or “high” standards of honesty and ethics. Also in the news: female body dummies for CPR training.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

New Cases And Low Vaccination Rates In Some Areas Raise Measles Concerns

January 31, 2024 Morning Briefing

Some states in the Northeast are reporting a rise in measles. That trend is expected to spread to westward, including to some spots where vaccination rates are low enough to raise alarms for the CDC.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Analysis Finds Premature Birth Rate Grew 12% From 2014 To 2022

January 31, 2024 Morning Briefing

In 2022, nearly 8.7% of U.S. births were premature, new data from the National Center for Health Statistics show. Black mothers were nearly twice as likely as white peers to give birth before full term. Also in the news: the VA will expand fertility treatment options to single vets and same-sex couples.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Hospital Industry Outlook Looking Good On Wall Street

January 31, 2024 Morning Briefing

Axios says rising demand for medical care is bringing “good vibes” to the hospital industry’s financial outlook, even as health insurers are left nervous. Also in the news: Humana expands its CenterWell care into new markets; Accompany Health launches; digital therapeutics; and more.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Lawmakers, AHA Highlight Need For Health Worker Anti-Violence Bill

January 31, 2024 Morning Briefing

House sponsors of the Safety from Violence for Healthcare Employees Act of 2023 urged action on the bill at a briefing hosted by the American Hospital Association, which endorses the measure.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Medicaid Outlines Plan To Help Pay For Pricey Sickle Cell Gene Therapies

January 31, 2024 Morning Briefing

The Centers for Medicare and Medicaid Services will pursue so-called outcomes-based agreements that would put discounts or rebates in place on two new expensive gene therapies if they don’t deliver promised results for patients with sickle cell disease.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Thousands Of Frontline Worker Covid Deaths Due To Govt. Failures: Report

January 31, 2024 Morning Briefing

A new study published in the BMJ calls attention to failures in the U.S. regulatory system that contributed to the deaths of thousands of frontline workers during the pandemic. Separate research shows up to 75% of adults have hidden an infectious illness in order to work, travel, or socialize.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Experimental Non-Opioid Pain Drug Achieves Success In Studies

January 31, 2024 Morning Briefing

Vertex Pharmaceuticals’ new drug works by blocking pain signals before they get to the brain and is expected to avoid some issues that opioid pain drugs cause via addiction. The new drug is sparking debate on how widely it would be used if it wins regulatory approval.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Morning Briefing for Wednesday, January 31, 2024

January 31, 2024 Morning Briefing

STD rates, measles cases, covid, Medicaid drug costs, violence against health workers, a non-opioid pain drug, and more are in the news.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Syphilis Cases Rise In US While Other STDs Fall Or Stay Flat

January 31, 2024 Morning Briefing

According to CDC data, syphilis incidences rose 9% in 2022, and have increased 80% since 2018. Gonorrhea cases dropped for the first time in a decade though.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

First Edition: Jan. 31, 2024

January 31, 2024 Morning Briefing

Today’s early morning highlights from the major news organizations.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
  • Previous
  • 361
  • 362
  • 363
  • 364
  • 365
  • Next

More From KFF Health News

An American flag blows in the wind next to a barbed-wire fence in front of a landscape of grasslands

End of Enhanced Obamacare Subsidies Puts Tribal Health Lifeline at Risk

New Medicaid Work Rules Likely To Hit Middle-Aged Adults Hard

A box of ivermectin tablets is shown in a pharmacy.

US Cancer Institute Studying Ivermectin’s ‘Ability To Kill Cancer Cells’

A photo of a woman sitting in a chair from the shoulders down. She is taking her blood pressure.

Obamacare Sign-Ups Drop, but the Extent Won’t Be Clear for Months

KFF

© 2026 KFF. All rights reserved.

  • About Us
  • Donate
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Staff
  • Republish Our Content
  • Email Sign-Up
  • X
  • Facebook
  • LinkedIn
  • Instagram
  • RSS

Powered by WordPress VIP

Thank you for your interest in supporting KFF Health News, the nation’s leading nonprofit newsroom focused on health and health policy. We distribute our journalism for free and without advertising through media partners of all sizes and in communities large and small. We appreciate all forms of engagement from our readers and listeners, and welcome your support.

KHN is an editorially independent program of KFF (Kaiser Family Foundation). You can support KHN by making a contribution to KFF, a non-profit charitable organization that is not associated with Kaiser Permanente.

Click the button below to go to KFF’s donation page which will provide more information and FAQs. Thank you!

Continue